This paper is in the following e-collection/theme issue:

Early Results in Infodemiology and Infoveillance (80) Public (e)Health, Digital Epidemiology and Public Health Informatics (758) Quality/Credibility of eHealth Information and Trust Issues (547) Obesity (89) Obesity and Nutrition as Public Health Problem (314) Information Seeking, Information Needs (486) Information Demand (34)

Published on in Vol 9 (2025)

This is a member publication of

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/68792, first published .
Quality Assessment of Medical Institutions’ Websites Regarding Prescription Drug Misuse of Glucagon-Like Peptide-1 Receptor Agonists by Off-Label Use for Weight Loss: Website Evaluation Study

Quality Assessment of Medical Institutions’ Websites Regarding Prescription Drug Misuse of Glucagon-Like Peptide-1 Receptor Agonists by Off-Label Use for Weight Loss: Website Evaluation Study

Quality Assessment of Medical Institutions’ Websites Regarding Prescription Drug Misuse of Glucagon-Like Peptide-1 Receptor Agonists by Off-Label Use for Weight Loss: Website Evaluation Study

Authors of this article:

Rie Oyama1 Author Orcid Image ;   Tsuyoshi Okuhara1 Author Orcid Image ;   Emi Furukawa2 Author Orcid Image ;   Hiroko Okada1 Author Orcid Image ;   Takahiro Kiuchi1 Author Orcid Image
Article Authors Cited by Tweetations Metrics

There are no citations yet available for this article according to Crossref .